REFERENCES
1. Agnelli G, Belch JJF, Baumgartner I, Giovas P, Hoffmann U. Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review. Atherosclerosis 2020;293:94-100.
2. Askew CD, Parmenter B, Leicht AS, Walker PJ, Golledge J. Exercise & Sports Science Australia (ESSA) position statement on exercise prescription for patients with peripheral arterial disease and intermittent claudication. J Sci Med Sport 2014;17:623-9.
3. Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 2017;69:1465-508.
4. Ratliff CR, Strider D, Rovnyak V. Quality of life in individuals with peripheral arterial disease who underwent toe amputations: a descriptive, cross-sectional study. Wound Manag Prev 2019;65:34-40.
5. Aiello A, Anichini R, Brocco E, et al. Italian Society of Diabetes. Treatment of peripheral arterial disease in diabetes: a consensus of the Italian Societies of Diabetes (SID, AMD), Radiology (SIRM) and Vascular Endovascular Surgery (SICVE). Nutr Metab Cardiovasc Dis 2014;24:355-69.
6. Giugliano G, Perrino C, Schiano V, et al. Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication. BMC Surg 2012;12 Suppl 1:S19.
7. Kemps H, Kränkel N, Dörr M, et al. Exercise training for patients with type 2 diabetes and cardiovascular disease: what to pursue and how to do it. A Position paper of the European association of preventive cardiology (EAPC). Eur J Prev Cardiol 2019;26:709-27.
8. Behroozian A, Beckman JA. Microvascular disease increases amputation in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol 2020;40:534-40.
9. Mohammedi K, Woodward M, Hirakawa Y, et al. ADVANCE Collaborative Group. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol 2016;15:129.
10. Mueller T, Hinterreiter F, Poelz W, Haltmayer M, Dieplinger B. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease. Vasc Med 2016;21:445-52.
11. Arora E, Maiya AG, Devasia T, Bhat R, Kamath G. Effect of supervised exercise program on individuals in peripheral arterial disease with Type 2 diabetes mellitus - a systematic review. Curr Diabetes Rev 2020;16:248-53.
12. Treat-Jacobson D, McDermott MM, Bronas UG, et al. American Heart Association Council on Peripheral Vascular Disease. Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American heart association. Circulation 2019;139:e10-33.
13. Kim K, Anderson EM, Scali ST, Ryan TE. Skeletal muscle mitochondrial dysfunction and oxidative stress in peripheral arterial disease: a unifying mechanism and therapeutic target. Antioxidants (Basel) 2020;9:E1304.
14. Andrade-Lima A, da Silva Junior N, Chehuen M, et al. Local and systemic inflammation and oxidative stress after a single bout of maximal walking in patients with symptomatic peripheral artery disease. J Cardiovasc Nurs 2020; doi: 10.1097/JCN.0000000000000686.
15. Andrade-Lima A, Silva Junior N, Chehuen M, et al. Walking training improves systemic and local pathophysiological processes in intermittent claudication. Eur J Vasc Endovasc Surg 2021;61:954-63.
16. Pipinos II, Judge AR, Selsby JT, et al. The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vasc Endovascular Surg 2007;41:481-9.
17. Lyu X, Li S, Peng S, Cai H, Liu G, Ran X. Intensive walking exercise for lower extremity peripheral arterial disease: a systematic review and meta-analysis. J Diabetes 2016;8:363-77.
18. Manfredini F, Conconi F, Malagoni AM, et al. Training guided by pain threshold speed. Effects of a home-based program on claudication. Int Angiol 2004;23:379-87.
19. Manfredini F, Malagoni AM, Mascoli F, et al. Training rather than walking: the test in -train out program for home-based rehabilitation in peripheral arteriopathy. Circ J 2008;72:946-52.
20. Malagoni AM, Vagnoni E, Felisatti M, et al. Evaluation of patient compliance, quality of life impact and cost-effectiveness of a “test in-train out” exercise-based rehabilitation program for patients with intermittent claudication. Circ J 2011;75:2128-34.
21. Lamberti N, Straudi S, Lissia E, et al. Home-based exercise for elderly patients with intermittent claudication limited by osteoarticular disorders - feasibility and effectiveness of a low-intensity programme. Vasa 2018;47:227-34.
22. Manfredini R, Lamberti N, Manfredini F, et al. Gender differences in outcomes following a pain-free, home-based exercise program for claudication. J Womens Health (Larchmt) 2019;28:1313-21.
23. Lamberti N, Malagoni AM, Ficarra V, et al. Structured home-based exercise versus invasive treatment: a mission impossible? Angiology 2016;67:772-80.
24. Manfredini F, Lamberti N, Guerzoni F, et al. Rehabilitative exercise reduced the impact of peripheral artery disease on vascular outcomes in elderly patients with claudication: a three-year single center retrospective study. J Clin Med 2019;8:E210.
25. Lamberti N, López-Soto PJ, Guerzoni F, et al. Changes in exercise capacity and risk of all-cause mortality in patients with peripheral artery disease: a 10-year retrospective cohort study. Intern Emerg Med 2020;15:289-98.
26. Lamberti N, Straudi S, Malagoni AM, et al. Effects of low-intensity endurance and resistance training on mobility in chronic stroke survivors: a pilot randomized controlled study. Eur J Phys Rehabil Med 2017;53:228-39.
27. Malagoni AM, Cavazza S, Ferraresi G, Grassi G, Felisatti M, et al. Effects of a “test in-train out” walking program versus supervised standard rehabilitation in chronic stroke patients: a feasibility and pilot randomized study. Eur J Phys Rehabil Med 2016;52:279-87.
28. Malagoni AM, Catizone L, Mandini S, et al. Acute and long-term effects of an exercise program for dialysis patients prescribed in hospital and performed at home. J Nephrol 2008;21:871-8.
29. Manfredini F, Mallamaci F, D'Arrigo G, et al. Exercise in patients on dialysis: a multicenter, randomized clinical trial. J Am Soc Nephrol 2017;28:1259-68.
30. Lamberti N, Straudi S, Donadi M, Tanaka H, Basaglia N, Manfredini F. Effectiveness of blood flow-restricted slow walking on mobility in severe multiple sclerosis: a pilot randomized trial. Scand J Med Sci Sports 2020;30:1999-2009.
31. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67.
32. Manfredini F, Lamberti N, Malagoni AM, et al. Reliability of the vascular claudication reporting in diabetic patients with peripheral arterial disease: a study with near-infrared spectroscopy. Angiology 2015;66:365-74.
33. Jansen SCP, van Nistelrooij LPJ, Scheltinga MRM, Rouwet EV, Teijink JAW, Vahl AC. Successful implementation of the exercise first approach for intermittent claudication in the netherlands is associated with few lower limb revascularisations. Eur J Vasc Endovasc Surg 2020;60:881-7.
34. Bouwens E, Klaphake S, Weststrate KJ, et al. Supervised exercise therapy and revascularization: single-center experience of intermittent claudication management. Vasc Med 2019;24:208-15.
35. Dipnarine K, Barak S, Martinez CA, Carmeli E, Stopka CB. Pain-free treadmill exercise for patients with intermittent claudication: are there gender differences? Vascular 2016;24:304-14.
36. Mika P, Konik A, Januszek R, et al. Comparison of two treadmill training programs on walking ability and endothelial function in intermittent claudication. Int J Cardiol 2013;168:838-42.
